Literature DB >> 20148638

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

Tewodros Mamo1, E Ashley Moseman, Nagesh Kolishetti, Carolina Salvador-Morales, Jinjun Shi, Daniel R Kuritzkes, Robert Langer, Ulrich von Andrian, Omid C Farokhzad.   

Abstract

Currently, there is no cure and no preventive vaccine for HIV/AIDS. Combination antiretroviral therapy has dramatically improved treatment, but it has to be taken for a lifetime, has major side effects and is ineffective in patients in whom the virus develops resistance. Nanotechnology is an emerging multidisciplinary field that is revolutionizing medicine in the 21st century. It has a vast potential to radically advance the treatment and prevention of HIV/AIDS. In this review, we discuss the challenges with the current treatment of the disease and shed light on the remarkable potential of nanotechnology to provide more effective treatment and prevention for HIV/AIDS by advancing antiretroviral therapy, gene therapy, immunotherapy, vaccinology and microbicides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148638      PMCID: PMC2861897          DOI: 10.2217/nnm.10.1

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  150 in total

Review 1.  Gels as vaginal drug delivery systems.

Authors:  J das Neves; M F Bahia
Journal:  Int J Pharm       Date:  2006-03-17       Impact factor: 5.875

2.  Merck's HIV vaccine flop brings vectors under closer scrutiny.

Authors:  Heidi Ledford
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908

3.  Patent life of antiretroviral drugs approved in the US from 1987 to 2007.

Authors:  Rosa Rodriguez-Monguio; Enrique Seoane-Vazquez
Journal:  AIDS Care       Date:  2009-06

Review 4.  HIV pharmacology: barriers to the eradication of HIV from the CNS.

Authors:  Bryan McGee; Nathalie Smith; Francesca Aweeka
Journal:  HIV Clin Trials       Date:  2006 May-Jun

Review 5.  Immunologic control of HIV-1.

Authors:  Rajesh T Gandhi; Bruce D Walker
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

6.  T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Authors:  Priti Kumar; Hong-Seok Ban; Sang-Soo Kim; Haoquan Wu; Todd Pearson; Dale L Greiner; Amale Laouar; Jiahong Yao; Viraga Haridas; Katsuyoshi Habiro; Yong-Guang Yang; Ji-Hoon Jeong; Kuen-Yong Lee; Yong-Hee Kim; Sung Wan Kim; Matthias Peipp; Georg H Fey; N Manjunath; Leonard D Shultz; Sang-Kyung Lee; Premlata Shankar
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

7.  Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.

Authors:  Takami Akagi; Xin Wang; Tomofumi Uto; Masanori Baba; Mitsuru Akashi
Journal:  Biomaterials       Date:  2007-04-20       Impact factor: 12.479

8.  Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.

Authors:  Tathagata Dutta; Hrushikesh B Agashe; Minakshi Garg; Prahlad Balakrishnan; Prahlad Balasubramanium; Madhulika Kabra; Narendra K Jain
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

9.  Amphiphilic poly{[alpha-maleic anhydride-omega-methoxy-poly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery.

Authors:  Jinfeng Xing; Liandong Deng; Jun Li; Anjie Dong
Journal:  Int J Nanomedicine       Date:  2009-10-19

Review 10.  HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?

Authors:  Klaus Uberla
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

View more
  54 in total

Review 1.  Nucleic acid aptamers: clinical applications and promising new horizons.

Authors:  X Ni; M Castanares; A Mukherjee; S E Lupold
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials.

Authors:  Upal Roy; Jesse Rodríguez; Paul Barber; José das Neves; Bruno Sarmento; Madhavan Nair
Journal:  Nanomedicine (Lond)       Date:  2015-09-24       Impact factor: 5.307

Review 3.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

4.  The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.

Authors:  David E Vance; Pariya L Fazeli; Joan S Grant; Larry Z Slater; James L Raper
Journal:  J Neurosci Nurs       Date:  2013-10       Impact factor: 1.230

Review 5.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

Review 6.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 7.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

8.  pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.

Authors:  Tao Zhang; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Biopharm       Date:  2011-06-26       Impact factor: 5.571

9.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

10.  Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.

Authors:  Asahi Tomitaka; Hamed Arami; Zaohua Huang; Andrea Raymond; Elizette Rodriguez; Yong Cai; Marcelo Febo; Yasushi Takemura; Madhavan Nair
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.